The IperionX Ltd (ASX: IPX) share price is in focus today after the company's March 2026 quarterly report revealed a shift to 24/7 continuous titanium powder production and a cash balance of US$48.2 million at quarter's end.
Image source: Getty Images
What did IperionX report?
- Transitioned Virginia operations to full 24/7 production, exiting commissioning phase
- HAMR™ powder production increased to ~4.2 metric tons in March, early ramp rate equivalent to 50 tpa annualised
- All powder production systems now commissioned and targeted to reach ~200 tpa run-rate by end 2026
- Quarter-end cash balance of US$48.2 million, with US$42.1 million in additional obligated US Government funding available
- Customer receipts remain early stage, reflecting focus on prototyping and qualification batches
What else do investors need to know?
IperionX's expansion plans are well supported, with the US Government fully obligating US$47.1 million for a 1,400 tpa titanium production scale-up. The company has also secured around 290 metric tons of titanium scrap from US agencies, providing about 1.5 years' feedstock at full operating capacity.
Development of the company's next-generation continuous HAMR™ (GenX™) platform progressed, with aims to lift productivity and cut costs. Additional high-capacity pressing and sintering equipment is due for commissioning in the next quarter, addressing current bottlenecks and supporting higher-volume titanium parts manufacturing.
What did IperionX management say?
CEO and Managing Director Anastasios Arima said:
The March 2026 quarter marked an important transition for IperionX: from commissioning into continuous operations, and from technology development toward repeatable commercial execution… Our immediate operating priorities are clear: increase titanium throughput, broaden product mix, improve production consistency and commission additional downstream capacity for customers.
What's next for IperionX?
Looking ahead, IperionX intends to continue ramping production at its Virginia manufacturing campus, aiming for a titanium powder run-rate of about 200 tpa by end-2026. Further growth to 1,400 tpa is planned, supported by ongoing US Government funding.
Parallel to operational scale-up, IperionX is pushing customer qualification programs and expects to see more defined purchase orders and revenue commencement in the second half of 2026. Completion of the Definitive Feasibility Study for the Titan critical minerals project in Tennessee by mid-year may pave the way for future expansion into titanium, rare earth, and zircon mineral supply.
IperionX share price snapshot
Over the past 12 months, IperionX shares have risen 30%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 9% over the same period.
